Trump tariffs may disrupt WTO rules, but pharma scrambles to prepare

European companies are in a hurry to prepare for the potential flow of US import duties, and even analysts, as well as “Tariff Taskforces,” said the accumulations in the sector.

Fresenius Medical Aid He says the first “Tariff Taskforce”, US President Donald Trump has installed the proposed trade expenses, the first “Tariff Taskforce” to manage uncertainty.

“It is clear that what is happening in the medical equipment of the tariffs and tariffs in Europe, and what medical equipment is happening,” Squawk Box Squawk Box “Squawk Box” CNBC “Squawk Box”.

“This is something we have gathered quickly and quickly with the escalation and speed, executive commands,” he said.

President Trump pointed out that the European Union could be with the face on Wednesday 25% sweep tariffs It reflects the threats similar to Canada and Mexico by exporting to the United States. Trump came after a week after all the pharmacy, automatically and the chip imports loaded a flat load around about 25%.

The proposal was concerned about some analysts, which will report that such tasks in the Pharma industry will be violated by the World Trade Organization – the United States.

According to the WTO Pharma Agreement, the majority of pharmaceutical products and the substances used to produce them are free from tariffs and closes them at duty-free levels. However, the Sector Economist, Diederik Stadig, in the ING, said the provision could not suffice to prevent the plan of the Leader of the White House.

“I do not think that the WTO violation will be sufficient to exempted from mutual tariffs,” said Stadig CNBC launched a “cautious work action” to the CNBC launched Task Task.

“It seems that the Trump leadership never pays attention (if he violates WTO),” Sydbank in Sydbank in Sydbank Sydbank in Sydbank Sydbank, Pharma capital analyst told CNBC on Friday.

A spokesman for the White House did not immediately respond to the desire to interpret CNBC’s probability of trade. A spokesman for the WTO Secretariat said, “It is” not commenting on the special actions of our members, “he said, but the participants could initiate the trial of concerns or dispute settlements on the actions of other members.

“These are the countries where the threat should be particularly true,” a stadig “wrote note last month.

The supply of dialysis and consumer products of a group of Fresenius Medical Seriary, tariffs, which is likely to be transported to the United States, will likely be taken to the United States.

Alcon CEO David Endicott, Swiss-American Pharmacy and Medical Device Company, “he pays very carefully,” he said. Despite seeing a direct exposure of directly, import-export, Endicott pointed out potential concerns around the supply chains, including raw material imports.

“We do not see a big exposure here, but it is a dynamic time,” he said on Wednesday.

Brian McNamara, General Director of the British Multinational Consumer Health Company HalonOn Thursday, despite the fact that most of the US sales of the US sales from local production, the business has been working in Canada and several more plants in Europe. “

One of the goals of Trump tariffs is to increase the production of companies and increase the US production of the United States. However, economists have questioned the logic of such strategy and the ability of companies to increase the strength of the president as long as the president wants.

“It will take time to build production plants and use empty production capacity,” said Stadig. “Secondly, the economies of the general API (active pharmaceutical substances) in India and China are so important that the total APIs are not cheap in the United States in the United States, and will soon prove Raw materials in the United States.”

Others warned that additional payments will only serve to push expenses in the US medical sector.

“Many companies have a global supply chain, so it will hurt companies or other people or other members of the US medical system,” Sydbank said.